Affordable Access

deepdyve-link
Publisher Website

Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes.

Authors
  • Levin, Philip
  • Wei, Wenhui
  • Wang, Li
  • Pan, Chunshen
  • Douglas, Damon
  • Baser, Onur
Type
Published Article
Journal
Current Medical Research and Opinion
Publisher
Informa UK (Librapharm)
Publication Date
March 2012
Volume
28
Issue
3
Pages
439–446
Identifiers
DOI: 10.1185/03007995.2012.654850
PMID: 22216894
Source
Medline
License
Unknown

Abstract

Combined therapy with insulin glargine and exenatide resulted in A1C reductions in T2DM patients with poor glycemic control without a significantly increased risk of hypoglycemia irrespective of treatment order. Limitations of this study are the between-cohort differences at baseline, lack of a comparator group, and small n number, particularly in the GLA + EXE cohort.

Report this publication

Statistics

Seen <100 times